The G7 Summit has wrapped up with pledges from world leaders to take urgent action on the COVID-19 pandemic, climate and possibly China. Canada's share is 100 million doses, a target signalled by the Liberal government at the onset of the three-day summit. The majority of it (7.3 million doses) will be the Novavax vaccine, which has not yet been approved by Health Canada. There will be 4.3 million doses from the AstraZeneca-Oxford supply and 1.3 million from the Johnson & Johnson stream. G7 leaders did agree on plans to transform the financing of infrastructure projects in developing countries.

Source: CBC News June 13, 2021 15:33 UTC